CALIFORNIA CITY, Calif. -
April 25, 2023 -
PRLog -- Clinical trials are crucial in determining the safety and effectiveness of new medical treatments and interventions. However, the technical and scientific jargon used in these trials can be complicated for the general public to understand. Lay summaries aim to bridge this gap by presenting trial results in plain language that is easy to comprehend. These summaries make clinical trial findings accessible and transparent to patients, caregivers, and the public. In this blog, we will explore the importance of lay summaries in the context of clinical trials and how they contribute to improving patient care and treatment options. Further, we will explore the additional information that lay summaries may provide and how it can aid in understanding the study results and their implications. Have a look at the storyboard below:
The additional information section may include any other details that may be relevant to understanding the study results or their implications
For example, it may include information on the trial design, the statistical analysis methods used, or any limitations or potential biases of the study.
Also, You can find some information about Study number, study synopsis, Protocol identification number, EudraCT number and ISRCTN number, details of the sponsor, Contact details for the sponsor and study reference details, etc.
https://www.acldigital.com/blogs/lay-summary-layman-summa...
Account Phone Number